Succinate receptor mediates intestinal inflammation and fibrosis-Reference-Cited by-同舟云学术

Succinate receptor mediates intestinal inflammation and fibrosis

Published:2018-10-02 Issue:1 Volume:12 Page:178-187
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Macias-Ceja Dulce C.,Ortiz-Masiá Dolores,Salvador Pedro,Gisbert-Ferrándiz Laura,Hernández Carlos,Hausmann Martin,Rogler Gerhard,Esplugues Juan V.,Hinojosa Joaquín,Alós Rafael,Navarro Francisco,Cosin-Roger Jesus,Calatayud Sara,Barrachina María D.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41385-018-0087-3.pdf

Reference38 articles.

1. Wynn, T. A. & Ramalingam, T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028–1040 (2012).

2. Rieder, F., Zimmermann, E. M., Remzi, F. H. & Sandborn, W. J. Crohn’s disease complicated by strictures: a systematic review. Gut 62, 1072–1084 (2013).

3. Li, C. & Kuemmerle, J. F. Mechanisms that mediate the development of fibrosis in patients with Crohn’s disease. Inflam. Bowel Dis. 20, 1250–1258 (2014).

4. Rieder, F., Fiocchi, C. & Rogler, G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology 152, 340–350 e346 (2017).

5. Mills, E. & O’neill, L. A. Succinate: a metabolic signal in inflammation. Trends Cell Biol. 24, 313–320 (2014).

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD Pathogenesis;International Journal of Molecular Sciences;2024-09-04

3. Natural Products on Inflammatory Bowel Disease: Role of Gut Microbes;The American Journal of Chinese Medicine;2024-08-28

4. Characterization of faecal microbiota and serum inflammatory markers in dogs diagnosed with chronic enteropathy or small-cell lymphoma: a pilot study;Scientific Reports;2024-08-20

5. The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease;Frontiers in Pharmacology;2024-07-25